Shandong Lukang Pharmaceutical Co.,Ltd. (SHA:600789)

SHA:600789 Revenue

Shandong Lukang Pharmaceutical had revenue of 1.62B CNY in the quarter ending June 30, 2026, with 9.53% growth. This brings the company's total for the last twelve months to 5.85B, down -4.22% year-over-year. In the year 2025, Shandong Lukang Pharmaceutical had annual revenue of 5.77B, down -7.49%. That makes Shandong Lukang Pharmaceutical the 8,229th largest company in the world by revenue and 1,250th in China.

• Revenue (ttm): 5.85B
• Revenue Growth: -4.22%
• P/S Ratio: 1.31
• Revenue / Employee: 904.30K
• Employees: 6,469
• Market Cap: 7.68B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 4.56B 79.9%
• Foreign 1.15B 20.1%

Fiscal year ended Dec 31, 2025 See the full SHA:600789 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.77B	-466.97M	-7.49%
Dec 31, 2024	6.23B	86.37M	1.41%
Dec 31, 2023	6.15B	525.28M	9.34%
Dec 31, 2022	5.62B	697.66M	14.17%
Dec 31, 2021	4.92B	718.67M	17.09%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error